Isolation and analysis of the vaccine potential of an attenuated Edwardsiella tarda strain

Vaccine

Volumn 28, Issue 38, 2010, Pages 6344-6350

  Sun, Yun ^a,b   Liu, Chun sheng ^a,c   Sun, Li ^a  

^a INSTITUTE OF OCEANOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c YELLOW SEA FISHERIES RESEARCH INSTITUTE   (China)

Author keywords

Edwardsiella tarda; Immersion; Live attenuated vaccine; Oral vaccine; Rifampicin resistance

Indexed keywords

IRON; LIVE VACCINE; RIFAMPICIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; AQUACULTURE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONTROLLED STUDY; EDWARDSIELLA TARDA; FLOUNDER; FRESHWATER FISH; GROWTH RATE; IMMERSION; INTESTINE; KIDNEY; LETHAL DOSE; LIVER; MARINE SPECIES; MUTANT; NONHUMAN; PRIORITY JOURNAL; SPLEEN; SURVIVAL; VACCINATION; WILD TYPE;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; EDWARDSIELLA TARDA; ENTEROBACTERIACEAE INFECTIONS; FISH DISEASES; FLOUNDER; INJECTIONS, INTRAPERITONEAL; VACCINATION; VACCINES, ATTENUATED;

EID: 77955655924     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.06.101     Document Type: Article

References (50)

1. Nelson J.J., Nelson C.A., Carter J.E. Extraintestinal manifestations of Edwardsiella tarda infection: a 10-year retrospective review. J La State Med Soc 2009, 161:103-106.
2. Slaven E.M., Lopez F.A., Hart S.M., Sanders C.V. Myonecrosis caused by Edwardsiella tarda: a case report and case series of extraintestinal E. tarda infections. Clin Infect Dis 2001, 32:1430-1433.
3. Janda J.M., Abbott S.L., Kroske-Bystrom S., Cheung W.K.W., Powers C., Kokka R.P., et al. Pathogenic properties of Edwardsiella species. J Clin Microbiol 1991, 29:1997-2001.
4. Matsuyama T., Kamaishi T., Ooseko N., Kurohara K., Iida T. Pathogenicity of motile and non-motile Edwardsiella tarda to some marine fish. Fish Pathol 2005, 40:133-135.
5. Swain P., Behura A., Dash S., Nayak S.K. Serum antibody response of Indian major carp, Labeo rohita to three species of pathogenic bacteria. Aeromonas hydrophila, Edwardsiella tarda and Pseudomonas fluorescens. Vet Immunol Immunopathol 2007, 117:137-141.
6. Thune R.L., Stanley L.A., Cooper R.K. Pathogenesis of gram negative bacterial infections in warm water fish. Annu Rev Fish Dis 1991, 3:37-68.
7. Castro N., Toranzo A.E., Barja J.L., Nunez S., Magarinos B. Characterization of Edwardsiella tarda strains isolated from turbot, Psetta maxima (L.). J Fish Dis 2006, 29:541-547.
8. Yang C.Z., Wang X.H., Huang J., Identification phylogenetic analysis of pathogen-Edwardsiella tarda from cultured turbot (Scophthalmus maximus). J Shanghai Fish Univ 2008, 17:280-284.
9. Castro N., Toranzo A.E., Nunez S., Magarinos B. Development of an effective Edwardsiella tarda vaccine for cultured turbot (Scophthalmus maximus). Fish Shellfish Immunol 2008, 25:208-212.
10. Kwon S.R., Nam Y.K., Kim S.K., Kim K.H. Protection of tilapia (Oreochromis mosambicus) from edwardsiellosis by vaccination with Edwardsiella tarda ghosts. Fish Shellfish Immunol 2006, 20:621-626.
11. Lee D.J., Kwon S.R., Zenke K., Lee E.H., Nam Y.K., Kim S.K., et al. Generation of safety enhanced Edwardsiella tarda ghost vaccine. Dis Aqua Organ 2008, 81:249-254.
12. Jiao X., Dang W., Hu Y., Sun L. Identification and immunoprotective analysis of an in vivo-induced Edwardsiella tarda antigen. Fish Shellfish Immunol 2009, 27:633-638.
13. Jiao X., Zhang M., Hu Y., Sun L. Construction and evaluation of DNA vaccines encoding Edwardsiella tarda antigens. Vaccine 2009, 27:5195-5202.
14. Cheng S., Hu Y., Zhang M., Sun L. Analysis of the vaccine potential of a natural avirulent Edwardsiella tarda isolate. Vaccine 2010, 28:2716-2721.
15. Mo Z.L., Xiao P., Mao Y.X., Zou Y.X., Wang B., Li J., et al. Construction and characterization of a live, attenuated esrB mutant of Edwardsiella tarda and its potential as a vaccine against the haemorrhagic septicaemia in turbot, Scophthamus maximus (L.). Fish Shellfish Immunol 2007, 23:521-530.
16. Entriken T.L. Veterinary pharmaceuticals and biologicals 2002, Veterinary Health Care Communications-Thomson Health Care, Montvale, NJ, USA. 12th ed.
17. Bader J.A., Shoemaker C.A., Klesius P.H. Production, characterization and evaluation of virulence of an adhesion defective mutant of Flavobacterium columnare produced by beta-lactam selection. Lett Appl Microbiol 2005, 40:123-127.
18. Shoemaker C.A., Klesius P.H., Evans J.J. Immunization of eyed channel catfish, Ictalurus punctatus, eggs with monovalent Flavobacterium columnare vaccine and bivalent F. columnare and Edwardsiella ictaluri vaccine. Vaccine 2007, 25:1126-1131.
19. Buchanan J.T., Stannard J.A., Lauth X., Ostland V.E., Powell H.C., Westerman M.E., et al. Streptococcus iniae phosphoglucomutase is a virulence factor and a target for vaccine development. Infect Immun 2005, 73:6935-6944.
20. Lawrence M.L., Banes M.M., Williams M.L. Phenotype and virulence of a transposon-derived lipopolysaccharide O side-chain mutant strain of Edwardsiella ictaluri. J Aquat Anim Health 2001, 13:291-299.
21. Liu Y., Bi Z. Potential use of a transposon Tn916-generated mutant of Aeromonas hydrophila J-1 defective in some exoproducts as a live attenuated vaccine. Prev Vet Med 2007, 78:79-84.
22. Norqvist A., Hagstrom A., Wolf-Watz H. Protection of rainbow trout against vibriosis and furunculosis by the use of attenuated strains of Vibrio anguillarum. Appl Environ Microbiol 1989, 55:1400-1405.
23. Alvarez B., Alvarez J., Menendez A., Guijarro J.A. A mutant in one of two exbD loci of a TonB system in Flavobacterium psychrophilum shows attenuated virulence and confers protection against cold water disease. Microbiology 2008, 154:1144-1151.
24. Daly J.G., Griffiths S.G., Kew A.K., Moore A.R., Olivier G. Characterization of attenuated Renibacterium salmoninarum strains and their use as live vaccines. Dis Aquat Org 2001, 44:121-126.
25. Lawrence M.L., Cooper R.K., Thune R.L. Attenuation, persistence, and vaccine potential of an Edwardsiella ictaluri purA mutant. Infect Immun 1997, 65:4642-4651.
26. Moral C.H., Castillo E.F.d., Fierro P.L., Cortes A.V., Castillo J.A., Soriano A.C., et al. Molecular characterization of the Aeromonas hydrophila aroA gene and potential use of an auxotrophic aroA mutant as a live attenuated vaccine. Infect Immun 1998, 66:1813-1821.
27. Vaughan L.M., Smith P.R., Foster T.J. An aromatic-dependent mutant of the fish pathogen Aeromonas salmonicida is attenuated in fish and is effective as a live vaccine against the salmonid disease furunculosis. Infect Immun 1993, 61:2172-2181.
28. Temprano A., Riano J., Yugueros J., Gonzalez P., de Castro L., Villena A., et al. Potential use of a Yersinia ruckeri O1 auxotrophic aroA mutant as a live attenuated vaccine. J Fish Dis 2005, 28:419-427.
29. Thornton J.C., Garduno R.A., Kay W.W. The development of live vaccines for furunculosis lacking the A-layer and O-antigen of Aeromonas salmonicida. J Fish Dis 1994, 17:195-204.
30. Thune R.L., Fernandez D.H., Battista J.R. An aroA mutant of Edwardsiella ictaluri is safe and efficacious as a live, attenuated vaccine. J Aquat Anim Health 1999, 11:358-372.
31. Bhatnagar N., Getachew E., Straley S., Williams J., Meltzer M., Fortier A. Reduced virulence of rifampicin-resistant mutants of Francisella tularensis. J Infect Dis 1994, 170:841-847.
32. Moorman D.R., Mandell G.L. Characteristics of rifampin-resistant variants obtained from clinical isolates of Staphylococcus aureus. Antimicrob Agents Chemother 1981, 20:709-713.
33. Klesius P.H., Shoemaker C.A. Development and use of modified live Edwardsiella ictaluri vaccine against enteric septicemia of catfish. Adv Vet Med 1999, 41:523-537.
34. LaFrentz B.R., LaPatra S.E., Call D.R., Cain K.D. Isolation of rifampicin resistant Flavobacterium psychrophilum strains and their potential as live attenuated vaccine candidates. Vaccine 2008, 26:5582-5589.
35. Hu Y., Dang D., Liu C., Hou J., Sun L. Analysis of the effect of copper on the virulence of a pathogenic Edwardsiella tarda strain. Lett Appl Microbiol 2010, 50:97-103.
36. Sambrook J., Fritsch E.F., Maniatis T. Molecular cloning: a laboratory manual 1989, Cold Spring Harbor Laboratory Press, New York.
37. Wang F., Cheng S., Sun K., Sun L. Molecular analysis of the fur (ferric uptake regulator) gene of a pathogenic Edwardsiella tarda strain. J Microbiol 2008, 46:350-355.
38. Sun K., Jiao X., Zhang M., Sun L. DNA adenine methylase is involved in the pathogenesis of Edwardsiella tarda. Vet Microbiol 2010, 141:149-154.
39. Zhang W., Sun L. Cloning, characterization and molecular application of a beta-agarase gene from Vibrio sp. strain V134. Appl Environ Microbiol 2007, 73:2825-2831.
40. Wang H., Hu Y., Zhang W., Sun L. Construction of an attenuated Pseudomonas fluorescens strain and evaluation of its potential as a cross-protective vaccine. Vaccine 2009, 27:4047-4055.
41. Vh, a serine protease and a protective immunogen from a pathogenic Vibrio harveyi strain. Appl Environ Microbiol 2008, 74:6254-6262.
42. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
43. Zhang M., Sun K., Sun L. Regulation of autoinducer 2 production and luxS expression in a pathogenic Edwardsiella tarda strain. Microbiology 2008, 154:2060-2069.
44. Amend D.F. Potency testing of fish vaccines. In: international symposium on fish biologics: serodiagnostics and vaccines. Dev Biol Standard 1981, 49:447-454.
45. Vogler A.J., Busch J.D., Percy-Fine S., Tipton-Hunton C., Smith K.L., Keim P. Molecular analysis of rifampin resistance in Bacillus anthracis and Bacillus cereus. Antimicrob Agents Chemother 2002, 46:51-53.
46. Valdezate S., Navarro A., Medina-Pascual M.J., Carrasco G., Saéz-Nieto J.A. Molecular screening for rifampicin and fluoroquinolone resistance in a clinical population of Brucella melitensis. J Antimicrob Chemother 2010, 65:51-53.
47. Billington O.J., McHughTD, Gillespie S.H. Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis. Antimicrob Agents Chemother 1999, 43:1866-1869.
48. Mariam D.H., Mengistu Y., Hoffner S.E., Andersson D.I. Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2004, 48:1289-1294.
49. Maughan H., Galeano B., Nicholson W.L. Novel rpoB mutations conferring rifampin resistance on Bacillus subtilis: global effects on growth, competence, sporulation, and germination. J Bacteriol 2004, 186:2481-2486.
50. Arias C.R., Shoemaker C.A., Evans J.J., Klesius P.H. A comparative study of Edwardsiella ictaluri parent (EILO) and E. ictaluri rifampicin-mutant (RE-33) isolates using lipopolysaccharides, outer membrane proteins, fatty acids, Biolog, API 20E and genomic analyses. J Fish Dis 2003, 26:415-421.